Gadolinium-based contrast agents (GBCAs) are intravenous drugs used in magnetic resonance imaging (MRI) to enhance the quality of the images. Gadolinium is a rare earth metal that improves the visibility of internal structures by altering the local magnetic field, thereby increasing the contrast of the images.
